Physician profile
Lillian Yang
NPI 1871855411
$944.93
in general payments reported to CMS, 2019-2025
12 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.67 · 2020: $37.79 · 2021: $268 · 2022: $89.60 · 2023: $141 · 2024: $227 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $495.59 | 2019-2025 | Clareon, Tryptyr, Rocklatan |
| Sun Pharmaceutical Industries INC. | $95.03 | 2023-2025 | Cequa |
| Biotissue Holdings INC. | $62.83 | 2022-2024 | |
| Harrow Eye, LLC | $60.03 | 2024-2025 | Vevye |
| Oyster Point Pharma, INC. | $53.67 | 2023-2024 | Tyrvaya |
| Bausch & Lomb Americas INC. | $32.68 | 2025 | Xiidra, Miebo |
| Rayner Intraocular Lenses Limited | $32.52 | 2024 | Omidria, Rayone Emv, Rayone Aspheric |
| Dompe US, INC. | $25.52 | 2024 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $22.54 | 2025 | Xdemvy |
| Beaver-Visitec International, INC. | $22.52 | 2021 | |
| Amgen INC. | $22.07 | 2024 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $19.93 | 2024 | Tecnis Iol, Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.